breast-cancer-research.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Breast Cancer Research
official impact factor 5.25
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Breast Cancer Research
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most popular RSS
  • Issues
  • Supplements
  • Article collections
Supplements
Please provide a volume number.

Page 1 of 82

1 2 3 4 5 6 7 8 9 10  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

Research article   Open Access

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time

Stephen W Duffy, Dharmishta Parmar Breast Cancer Research 2013, 15:R41 (16 May 2013)

Abstract | Provisional PDF | PubMed

Editorial   Free

Illuminating luminal B: QSOX1 as a subtype-specific biomarker

Padmalaya Das, Gabrielle M Siegers, Lynne-Marie Postovit Breast Cancer Research 2013, 15:104 (15 May 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access

High mammographic density in women of Ashkenazi Jewish descent

Jennifer L Caswell, Karla Kerlikowske, John A Shepherd, Steven R Cummings, Donglei Hu, Scott Huntsman, Elad Ziv Breast Cancer Research 2013, 15:R40 (13 May 2013)

Abstract | Provisional PDF | PubMed

Research article   Open Access

The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors

Wen-Wei Chang, Ruey-Jen Lin, John Yu, Wen-Ying Chang, Chiung-Hui Fu, Alan Chuan-Ying Lai, Jyh-Cherng Yu, Alice L Yu Breast Cancer Research 2013, 15:R39 (12 May 2013)

Abstract | Provisional PDF | PubMed

Research article   Open Access

Progesterone metabolites regulate induction, growth and suppression of estrogen- and progesterone receptor-negative human breast cell tumors

John P Wiebe, Guihua Zhang, Ian Welch, Heather-Anne T Cadieux-Pitre Breast Cancer Research 2013, 15:R38 (11 May 2013)

Abstract | Provisional PDF | PubMed

Research article   Open Access

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15

Jacqueline Lehmann-Che, Anne Sophie Hamy, Raphael Porcher, Marc Barritault, Fatiha Bouhidel, Hanadi Habuellelah, Solenne Leman-Detours, Anne de Roquancourt, Laurence Cahen-Doidy, Edwige Bourstyn, Patricia de Cremoux, Cedric de Bazelaire, Marcela Albiter, Sylvie Giacchetti, Caroline Cuvier, Anne Janin, Marc Espie, Hugues de The, Philippe Bertheau Breast Cancer Research 2013, 15:R37 (11 May 2013)

Abstract | Provisional PDF | PubMed |  Editor’s summary

A novel and simplified molecular and immunohistochemical signature has been described for molecular apocrine breast tumours which could help with easy identification in clinical practice.

Review   Subscription

Delivery of gene silencing agents for breast cancer therapy

Haifa Shen, Vivek Mittal, Mauro Ferrari, Jenny Chang Breast Cancer Research 2013, 15:205 (8 May 2013)

Abstract | Full text | PDF | PubMed

Editorial   Free Highly Accessed

Pregnancy protection of breast cancer: new insights reveal unanswered questions

Daniel Medina Breast Cancer Research 2013, 15:103 (8 May 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium

Fabienne Meier-Abt, Emanuela Milani, Tim Roloff, Heike Brinkhaus, Stephan Duss, Dominique S Meyer, Ina Klebba, Piotr J Balwierz, Erik van Nimwegen, Mohamed Bentires-Alj Breast Cancer Research 2013, 15:R36 (29 April 2013)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Early parity in mice alters the genomic signature of a distinct subset of mammary epithelial cells by inducing differentiation and reducing proliferation, ultimately protecting against breast cancer.

Research article   Open Access Highly Accessed

Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience

Paul M Meaney, Peter A Kaufman, Lori S Muffly, Michael Click, Stephen P Poplack, Wendy A Wells, Gary N Schwartz, Roberta M di Florio-Alexander, Tor D Tosteson, Zhongze Li, Shireen D Geimer, Margaret W Fanning, Tian Zhou, Neil R Epstein, Keith D Paulsen Breast Cancer Research 2013, 15:R35 (24 April 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Microwave imaging may provide a low cost alternative to magnetic resonance and positron emission tomography for monitoring patient response to neoadjuvant chemotherapy (NCT).

Review   Subscription Highly Accessed

The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker

Michael L Salmans, Fang Zhao, Bogi Andersen Breast Cancer Research 2013, 15:204 (24 April 2013)

Abstract | Full text | PDF | PubMed

Viewpoint   Subscription

Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression

Swarnali Acharyya Breast Cancer Research 2013, 15:309 (23 April 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study

Roni T Falk, Louise A Brinton, Joanne F Dorgan, Barbara J Fuhrman, Timothy D Veenstra, Xia Xu, Gretchen L Gierach Breast Cancer Research 2013, 15:R34 (22 April 2013)

Abstract | Provisional PDF | PubMed

Research article   Open Access Highly Accessed

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

Muhammad Riaz, Marijn TM van Jaarsveld, Antoinette Hollestelle, Wendy JC Prager-van der Smissen, Anouk AJ Heine, Antonius WM Boersma, Jingjing Liu, Jean Helmijr, Bahar Ozturk, Marcel Smid, Erik A Wiemer, John A Foekens, John WM Martens Breast Cancer Research 2013, 15:R33 (19 April 2013)

Abstract | Provisional PDF | PubMed

Research article   Open Access Highly Accessed

Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling

Lopamudra Roy, Jennifer M Curry, Mahnaz Sahraei, Dahlia M Besmer, Amritha Kidiyoor, Helen E Gruber, Pinku Mukherjee Breast Cancer Research 2013, 15:R32 (11 April 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

A mouse model of rheumatoid arthritis shows that SCF/c-Kit signalling mast cells accumulate in bone and lung metastatic niches, which enhances breast cancer metastasis.

Research article   Open Access

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

Alison F Munro, Annette Bartels, Eva Balslev, Christopher J Twelves, David A Cameron, Nils Brünner, John MS Bartlett Breast Cancer Research 2013, 15:R31 (9 April 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access

HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma

Nirukshi U Samarajeewa, Fangyuan Yang, Maria M Docanto, Minako Sakurai, Keely M McNamara, Hironobu Sasano, Stephen B Fox, Evan R Simpson, Kristy A Brown Breast Cancer Research 2013, 15:R30 (8 April 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer

Rita D Brandão, Jürgen Veeck, Koen K Van de Vijver, Patrick Lindsey, Bart de Vries, Catharina HMJ van Elssen, Marinus J Blok, Kristien Keymeulen, Torik Ayoubi, Hubert JM Smeets, Vivianne C Tjan-Heijnen, Pierre S Hupperets Breast Cancer Research 2013, 15:R29 (8 April 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

A randomized controlled trial finds that celecoxib, a COX-2 inhibitor, induces anti-tumor transcriptional changes in primary breast cancer tissue, suggesting a use for celecoxib in future treatments.

Viewpoint   Subscription

Closing escape routes: inhibition of IL-8 signaling enhances the anti-tumor efficacy of PI3K inhibitors

Ashish Juvekar, Gerburg M Wulf Breast Cancer Research 2013, 15:308 (8 April 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer

Benjamin A Katchman, I Tolgay Ocal, Heather E Cunliffe, Yu-Hui Chang, Galen Hostetter, Aprill Watanabe, Janine LoBello, Douglas F Lake Breast Cancer Research 2013, 15:R28 (28 March 2013)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Subscription Highly Accessed

The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy

Mun Hui, Aurélie Cazet, Radhika Nair, D Watkins, Sandra A O'Toole, Alexander Swarbrick Breast Cancer Research 2013, 15:203 (28 March 2013)

Abstract | Full text | PDF | PubMed

Viewpoint   Subscription Highly Accessed

Elf5 - breast cancer's little helper

Hayley T Frend, Christine J Watson Breast Cancer Research 2013, 15:307 (27 March 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Risk of breast cancer in Lynch syndrome: a systematic review

Aung Win, Noralane M Lindor, Mark A Jenkins Breast Cancer Research 2013, 15:R27 (19 March 2013)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer

Sepideh Gholami, Chun-Hao Chen, Laurence J Belin, Emil Lou, Sho Fujisawa, Caroline Antonacci, Amanda Carew, Nanhai G Chen, Marina De Brot, Pat B Zanzonico, Aladar A Szalay, Yuman Fong Breast Cancer Research 2013, 15:R26 (18 March 2013)

Abstract | Provisional PDF | PubMed |  Editor’s summary

Oncolytic vaccinia virus, GLV1h-153, engineered to express the human sodium iodide symporter (hNIS) gene is useful in imaging cancers and can be used to identify and treat positive surgical margins of breast cancer in mice.

Research article   Open Access

Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers

Marketa Zvelebil, Erik Oliemuller, Qiong Gao, Olivia Wansbury, Alan Mackay, Howard Kendrick, Matthew J Smalley, Jorge S Reis-Filho, Beatrice A Howard Breast Cancer Research 2013, 15:R25 (18 March 2013)

Abstract | Full text | PDF | PubMed

Page 1 of 82

1 2 3 4 5 6 7 8 9 10  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.